Here we are almost 1 year to the BETONMACE trial completion that although barely missed the primary endpoint and was trending in the right direction  but had very good secondary endpoints one would think had  RVX extended the trial it would have met the primary endpoint. Since then RVX has obtained an BTD with the FDA and the FDA is now onboard for the BETONMACE2 trial.    We have already heard from DM that RVX will be going the partnership route with a BP going forward but so far all we heard on that front is crickets.  Most recently 3 insiders have plunked down $40 thousand and now Hepa has stepped forwards once again with $2.7 million.  If those insiders were not 100% confident on a large BP deal to some degree i really doubt they would want to throw away that much money.  The large question is this recent financing an indication that a large deal with a BP is quite aways off as discussions are still going on and on and on with no close negotiations with a finalized partnership deal.  At this point i am not too sure how long a deal will take  but following the smart money indicates a deal will happen at some point in the near future, That future could well be in 2021??